Scope
Reference
C366698
Description
NHS National Framework for Golimumab Injection commencing 1st November 2025
Offer reference number: CM/TNS/25/5724
Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Framework
Maximum percentage fee charged to suppliers
0%
Framework operation description
Please refer to the ITO Documents for the Operation Description
Award method when using the framework
With competition
Contracting authorities that may use the framework
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Contracting authority location restrictions
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Contract 2. NHS National Framework for Golimumab Injection commencing 1st November 2025
Suppliers (3)
Contract value
- £60,000,000 excluding VAT
- £72,000,000 including VAT
Above the relevant threshold
Date signed
23 September 2025
Contract dates
- 1 November 2025 to 31 October 2026
- Possible extension to 31 October 2029
- 4 years
Description of possible extension:
option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Signed contract documents
CONTRACT COPY - Docs - Contract Details Notice CM-TNS-25-5724.pdf
CONTRACT COPY - Docs - Contract Details Notice CM-TNS-25-5724
Other information
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Suppliers
Janssen Cilag Ltd
- Companies House: 01027904
50-100 Holmers Farm Way
High Wycombe
HP12 4EG
United Kingdom
Email: commercialjc@its.jnj.com
Region: UKJ13 - Buckinghamshire CC
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. NHS National Framework for Golimumab Injection commencing 1st November 2025
MERCURY PHARMACEUTICALS LIMITED
- Companies House: 02619880
Dashwood House
London
EC2M 1QS
United Kingdom
Region: UKI31 - Camden and City of London
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. NHS National Framework for Golimumab Injection commencing 1st November 2025
ORIFARM UK LTD
- Companies House: 10015046
Ground Floor, Suite A2 Breakspear Way
Hemel Hempstead
HP2 4TZ
United Kingdom
Email: uk_enquiries@orifarm.com
Region: UKH23 - Hertfordshire
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 2. NHS National Framework for Golimumab Injection commencing 1st November 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government